Morgan Stanley Armata Pharmaceuticals, Inc. Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
A detailed history of Morgan Stanley transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 109 shares of ARMP stock, worth $214. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109
Previous 109
-0.0%
Holding current value
$214
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ARMP
# of Institutions
28Shares Held
740KCall Options Held
300Put Options Held
1K-
Vanguard Group Inc Valley Forge, PA260KShares$512,3430.0% of portfolio
-
Geode Capital Management, LLC Boston, MA106KShares$208,4980.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$197,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$88,0230.0% of portfolio
-
State Street Corp Boston, MA40.3KShares$79,3910.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $71.2M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...